EUVIMEDEUVIMED entdecken
Crossref

SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway

Ouli Long, Chunling Yang, Mengmeng Yu, Pailan Peng

Oncology Letters · 18.11.2026 · 33 (1) · 1-14

DOI: 10.3892/ol.2026.15951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 18.11.2026. Verfasst von Ouli Long und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Long, O., Yang, C., Yu, M., & Peng, P. (2026). SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway. Oncology Letters, 33(1), 1-14. https://doi.org/10.3892/ol.2026.15951

Vancouver

Long O, Yang C, Yu M, Peng P. SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway. Oncology Letters. 2026;33(1):1-14. doi:10.3892/ol.2026.15951

BibTeX
@article{Long2026,
  author = {Long, Ouli and Yang, Chunling and Yu, Mengmeng and Peng, Pailan},
  title = {SLC10A3 promotes liver cancer progression via modulation of the TGF‑β signaling pathway},
  journal = {Oncology Letters},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {1--14},
  doi = {10.3892/ol.2026.15951}
}
Kostenlos starten →